C09992122 / invoice 10000
Species:CANINE
Breed:English Mastiff
Age (years):11
Diagnosis or signs:see history attached
Consult notes
05/03/2026 Diagnosis:: Diffuse large cell lymphoma (histological diagnosis), Stage IIIA. IHC B -Cell. Vincristine week 13. History: Alice has finished her course of enrofloxacin a week ago, her appetite has improved but since starting chemotherapy treatment she remains lethargic. Toileting habits remain normal Physical Examination findings: Bright, alert and responsive. Oral exam: moderate dental disease, otherwise unremarkable. Heart & lungs: no murmur or arrythmia. Normal RE and BV sounds bilaterally Abdomen: soft and comfortable Lymph nodes: no lymphadenopathy Rectal: no internal lymphadenopathy Integ: right hock mildly odematous and warm at touch, coat NAD Mm pink, crt < 2 secs, HR 140, RR pant, Temp 38.2, Wt: 41.9kg Laboratory results: CBC performed in house with manual blood film assessment. Hct:0.386 WCC:6.38 Neuts:3.70 Platelets:521 Manual differential count: 52%, Lymphocytes 44%, Monocytes 3%, Eosinophils 1%. Platelets: clumped and adequate Morphology: Normal In-house CRP: 6.4 mg/L Treatment: 0.85mg vincristine (0.7mg/m2) was administered IV via a 22g catheter in the left lateral saphenous vein using the closed injection Equashield system. Cerenia as required Comments:t was a pleasure to see Alice. Although her hock appears oedematous and warm to the touch, her body temperature and blood parameters are within normal limits. Consequently, she no longer requires antibiotics; however, continued monitoring is recommended. We will see Alice again in 1 weeks' time. Please feel free to call or email if you have any further queries regarding Alice.
Previous claim history (8)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-09 | C09888534 | SEPTIC ARTHRITIS |
| 2026-02-07 | C09875846 | LYMPHOMA (MALIGNANT) |
| 2026-02-05 | C09858123 | LYMPHOMA (MALIGNANT) |
| 2026-01-22 | C09796558 | LYMPHOMA (MALIGNANT) |
| 2026-01-15 | C09763337 | LYMPHOMA (MALIGNANT) |
| 2026-01-02 | C09700703 | LYMPHOMA (MALIGNANT) |
| 2025-12-18 | C09646818 | LYMPHOMA (MALIGNANT) |
| 2025-12-11 | C09612836 | LYMPHOMA (MALIGNANT) |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_diagnostic_test_-_haematology | 126.50 | 2026-03-05 | — |
| 20000 | tstarc_chemotherapy | 285.00 | 2026-03-05 | — |
| 30000 | tstarc_consultation-revisit | 205.00 | 2026-03-05 | — |
| 40000 | tstarc_chemotherapy_-_vincristine | 75.00 | 2026-03-05 | — |
| 50000 | tstarc_diagnostic_test_-_blood_test | 46.07 | 2026-03-05 | — |
UPM+
- DG02636LYMPHOMA (MALIGNANT)DSTP_lymphoma
Variant (sleepy_king)
LYMPHOMA (MALIGNANT)
DSTP_lymphoma
Conf: 0.980
Threshold: 0.19
Above: ✓
Correct?